Product Description
Given the high prevalence of gastrointestinal complaints in pets, coupled with inconsistent efficacy and strain variability in existing probiotic products, we leverage microbiome research (gut microbiota sequencing) to inform targeted probiotic, postbiotic, and synbiotic development. Our core technologies—including microencapsulation for gastric acid resistance and intestinal colonization—ensure stable, effective live bacterial formulations. We also develop therapeutic diets for the management of food intolerances and chronic enteropathy, addressing the root causes of gastrointestinal distress.
